Integrated Filing — IndAS


General information about company

Scrip Code 543264
NSE Symbol NURECA
MSEI Symbol NOTLISTED
ISIN INE0DSF01015
Name of company NURECA LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 05-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 28-Apr-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment NOT APPLICABLE
Start date and time of board meeting 05-May-2025   16:30:00
End date and time of board meeting 05-May-2025   18:25:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 317400000 1096610000
Other income 19930000 124350000
Total income 337330000 1220960000
2 Expenses
(a) Cost of materials consumed 38550000 112910000
(b) Purchases of stock-in-trade 251590000 636760000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -100430000 -69550000
(d) Employee benefit expense 42700000 153070000
(e) Finance costs 6200000 12140000
(f) Depreciation, depletion and amortisation expense 5220000 23380000
(f) Other Expenses
1 Other expenses 72990000 338820000
Total other expenses 72990000 338820000
Total expenses 316820000 1207530000
3 Total profit before exceptional items and tax 20510000 13430000
4 Exceptional items 0 0
5 Total profit before tax 20510000 13430000
6 Tax expense
7 Current tax -19340000 -8170000
8 Deferred tax 15180000 13140000
9 Total tax expenses -4160000 4970000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 24670000 8460000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 24670000 8460000
17 Other comprehensive income net of taxes 3060000 3280000
18 Total Comprehensive Income for the period 27730000 11740000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 0 0
Total profit or loss, attributable to non-controlling interests 0 0
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 0 0
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0 0
21 Details of equity share capital
Paid-up equity share capital 100000000 100000000
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 0
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 2.47 0.85
Diluted earnings (loss) per share from continuing operations 2.47 0.85
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 2.47 0.85
Diluted earnings (loss) per share from continuing and discontinued operations 2.47 0.85
24 Debt equity ratio 0 0.0001
25 Debt service coverage ratio 0 0.0215
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 48140000
Capital work-in-progress 0
Investment property 0
Goodwill 0
Other intangible assets 19830000
Intangible assets under development 0
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 0
Trade receivables, non-current 0
Loans, non-current 0
Other non-current financial assets 0
Total non-current financial assets 0
Deferred tax assets (net) 34750000
Other non-current assets 97510000
Total non-current assets 200230000
2 Current assets
Inventories 399180000
Current financial asset
Current investments 10430000
Trade receivables, current 33220000
Cash and cash equivalents 32410000
Bank balance other than cash and cash equivalents 430120000
Loans, current 0
Other current financial assets 829510000
Total current financial assets 1335690000
Current tax assets (net) 0
Other current assets 164660000
Total current assets 1899530000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 2099760000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 100000000
Other equity 1842850000
Total equity attributable to owners of parent 1942850000
Non controlling interest 0
Total equity 1942850000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 10470000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 0
Total non-current financial liabilities 10470000
Provisions, non-current 7020000
Deferred tax liabilities (net) 0
Deferred government grants, Non-current 0
Other non-current liabilities 15430000
Total non-current liabilities 32920000
Current liabilities
Current financial liabilities
Borrowings, current 13250000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 11630000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 53960000
Total Trade payable 65590000
Other current financial liabilities 18170000
Total current financial liabilities 97010000
Other current liabilities 23930000
Provisions, current 2300000
Current tax liabilities (Net) 750000
Deferred government grants, Current
Total current liabilities 123990000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 156910000
Total equity and liabilites 2099760000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to Profit and Loss 4030000 4430000
Total Amount of items that will not be reclassified to profit and loss 4030000 4430000
2 Income tax relating to items that will not be reclassified to profit or loss 970000 1070000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0 80000
5 Total Other comprehensive income 3060000 3280000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 13430000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 12140000
Adjustments for decrease (increase) in inventories -90670000
Adjustments for decrease (increase) in trade receivables, current -17070000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -21110000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 14450000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities -9800000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 23380000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 2310000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 17250000
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains -590000
Adjustments for dividend income 0
Adjustments for interest income 76200000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items -44590000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -190500000
Net cash flows from (used in) operations -177070000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 13760000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities -190830000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 0
Purchase of property, plant and equipment 43230000
Proceeds from sales of investment property 290000
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 76200000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 51130000
Net cash flows from (used in) investing activities 84390000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 20840000
Repayments of borrowings 1960000
Payments of lease liabilities 10710000
Dividends paid 0
Interest paid 9860000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -1690000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -108130000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents -80000
Net increase (decrease) in cash and cash equivalents -108210000
Cash and cash equivalents cash flow statement at beginning of period 140620000
Cash and cash equivalents cash flow statement at end of period 32410000







Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 BSR & Co LLP Yes 31-Jul-2025


Financial details

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth




Signatories detail

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date